2025-11-23 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc. (HIMS) based on the data provided, formatted for a report.

## Hims & Hers Health Inc. (HIMS) Stock Analysis

**Company Overview:** Hims & Hers Health Inc. is a telehealth company that offers personalized health and wellness solutions directly to consumers.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (HIMS):** 125.95%
*   **Cumulative Return (VOO):** 68.76%
*   **Return Spread (HIMS - VOO):** 68.19%
*   **Spread Range:** Max: 321.5, Min: -86.2
*   **Relative Spread:** 37.8

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) in terms of cumulative return. The return spread of 68.19% indicates a considerable difference in performance. The relative spread of 37.8 suggests that the current spread is below the median but closer to the minimum, indicating recent underperformance or market correction relative to its historical volatility against the S\&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR      | MDD   | Alpha    | Beta | Cap(B) |
| ---------- | --------- | ----- | -------- | ---- | ------ |
| 2019-2021  | -42.0%    | 74.4% | -81.0%   | 0.0  | 1.5    |
| 2020-2022  | -19.0%    | 78.6% | -18.0%   | -0.0 | 1.5    |
| 2021-2023  | -65.0%    | 78.6% | -67.0%   | -0.1 | 2.0    |
| 2022-2024  | 119.0%    | 79.4% | 98.0%    | -0.0 | 5.5    |
| 2023-2025  | 130.0%    | 80.8% | 71.0%    | 0.1  | 7.9    |

**Analysis:** The table presents a mixed performance picture. While recent periods (2022-2025) show strong positive CAGR and Alpha, earlier periods (2019-2023) show significant losses. The consistently high MDD (Maximum Drawdown) indicates high volatility. Beta values fluctuate around zero, suggesting HIMS's returns have been relatively uncorrelated with the broader market, particularly over shorter time frames, and have become more sensitive recently. The market capitalization(Cap) has generally increased over the period.

### 2. Recent Stock Price Action

*   **Current Price:** \$34.71
*   **Previous Close:** \$33.62
*   **Change:** 3.24%
*   **5-Day Moving Average:** \$35.20
*   **20-Day Moving Average:** \$40.83
*   **60-Day Moving Average:** \$48.85

**Analysis:** The stock price increased by 3.24% from the previous close, but is still trading below its 5-day, 20-day, and 60-day moving averages, suggesting a recent downtrend despite the current uptick.

### 3. Market Risk Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 18.77 (Oversold)
*   **PPO:** -1.32
*   **Recent Relative Divergence Change (20-day):** -6.5 (Negative - Short-term Decline)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (17 shares - Very Safe - MRI:0.90) Monthly invest 1.3% of total investment (\$1,000.00) (Cash Ratio: 0% on 2025-10-01)
*   **Expected Return:** 17.1% (Long-term, vs. S&P 500)

**Analysis:** The MRI of 0.8 suggests a medium level of investment risk. The RSI value indicates that the stock is currently oversold, which can sometimes signal a potential buying opportunity. The negative PPO suggests that the short-term moving average is below the long-term moving average, potentially confirming the downtrend.  The Hybrid Signal recommends buying with full cash allocation and continued monthly investment. The negative change in relative divergence supports the downtrend identified from the moving averages. The expected return of 17.1% suggests a potentially attractive long-term return compared to the S&P 500.

### 4. Recent News & Significant Events

*   **[2025-11-21]** Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model
*   **[2025-11-20]** OMCL or HIMS: Which Is the Better Value Stock Right Now?
*   **[2025-11-19]** HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
*   **[2025-11-19]** Hims & Hers Health Insider Sold Shares Worth $853,490
*   **[2025-11-18]** Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell?
*   **[2025-11-18]** Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?

**Analysis:** The news headlines present a mixed picture.  The acceleration of their care model is a positive development. However, articles discussing a significant price plunge, insider selling, and whether to "hop on" the "roller coaster ride" suggest volatility and uncertainty. The comparison with OMCL as a value stock is also relevant.

### 4-2. Analyst Opinions

*   **Consensus:** Hold
*   **Mean Rating:** 2.86 (~Hold)
*   **Number of Opinions:** 12
*   **Target Price:** Avg: \$46.00, High: \$85.00, Low: \$25.00

**Analysis:** The analyst consensus is "Hold," with a mean rating around that level. The target price range is wide, indicating differing opinions on the stock's future performance.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue     |
| ---------- | ---- | ----------- |
| 2025-11-03 | 0.07 | \$0.60 B    |
| 2025-08-04 | 0.19 | \$0.54 B    |
| 2025-05-05 | 0.22 | \$0.59 B    |
| 2024-11-04 | 0.35 | \$0.40 B    |
| 2025-11-03 | 0.35 | \$0.40 B    |

**Analysis:** The company has shown recent profitability in terms of EPS. Over the last quarters, revenue has generally been increasing, suggesting growth.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
| ------------ | ---------- | ------------- |
| 2025-09-30   | \$0.60B    | 73.80%        |
| 2025-06-30   | \$0.54B    | 76.39%        |
| 2025-03-31   | \$0.59B    | 73.50%        |
| 2024-12-31   | \$0.48B    | 76.81%        |
| 2024-09-30   | \$0.40B    | 79.16%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE        |
| ------------ | ---------- | ---------- |
| 2025-09-30   | \$0.58B    | 2.72%      |
| 2025-06-30   | \$0.56B    | 7.55%      |
| 2025-03-31   | \$0.55B    | 9.01%      |
| 2024-12-31   | \$0.48B    | 5.46%      |
| 2024-09-30   | \$0.44B    | 17.18%     |

**Analysis:** Revenue has been steadily increasing. Profit margins remain high. Equity has also shown growth. However, ROE has been volatile, and generally decreasing.

### 7. Overall Summary

Hims & Hers Health Inc. (HIMS) presents a mixed investment picture. While the company has demonstrated strong growth and profitability recently, its stock has been highly volatile, and recent price action has been negative. The analyst consensus is "Hold," reflecting this uncertainty.  The positive EPS and rising revenue are encouraging, as is the high profit margin. However, the high MDD, recent price declines, insider selling, and decreasing ROE raise concerns. The RSI indicating an oversold condition, combined with a positive long-term expected return compared to the S\&P 500, could suggest a potential entry point for long-term investors willing to tolerate significant volatility. The recent jump in price should be monitored closely to see if it reverses the recent downtrend.
